EXtending the Time Window for Thrombolysis in Posterior Circulation Stroke Without Early CT Signs

PHASE3CompletedINTERVENTIONAL
Enrollment

234

Participants

Timeline

Start Date

August 17, 2022

Primary Completion Date

August 15, 2024

Study Completion Date

August 15, 2024

Conditions
Stroke, Acute Ischemic
Interventions
DRUG

Tissue Plasminogen Activator (Alteplase)

"Tissue Plasminogen Activator (Alteplase) 0.9 mg/kg up to a maximum of 90mg, intravenous, 10% as bolus and the remainder over 1 hour~Other Names:~Actilyse Activase tPA r-tPA"

Trial Locations (27)

Unknown

People's Hospital of Anji, Anji

Botou City Hospital, Botou

Dongyang Affiliated Hospital of Wenzhou Medical University, Dongyang

Haiyan People's Hospital, Haiyan

Hangzhou First People's Hospital, Hangzhou

Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou

Huzhou Central Hospital, Huzhou

Huzhou First People's Hospital, Huzhou

Nanxun District People's Hospital, Huzhou

South Taihu Hospital Affiliated to Huzhou College, Huzhou

The First People's Hospital Jiashan, Jiashan

First Affiliated Hospital of Jiaxing University, Jiaxing

Jiaxing Hospital of T.C.M, Jiaxing

Second Affiliated Hospital of Jiaxing University, Jiaxing

Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua

Longyan First Hospital, Longyan

Rui'an People's Hospital, Rui’an

China Medical University Shaoxing Hospital, Shaoxing

Shengzhou People's Hospital, Shengzhou

Taizhou Central Hospital, Taizhou

Taizhou Hospital of Zhejiang Province, Taizhou

The First People's Hospital of Wenling, Wenling

Yongjia People's Hospital, Yongjia

Yueqing People's Hospital, Yueqing

Zhejiang Hospital, Zhejiang

The First People's Hospital Daishan, Zhoushan

Zhuji Affiliated Hospital of Wenzhou Medical University, Zhuji

All Listed Sponsors
lead

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER